Higher serum interleukin‐17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus‐associated advanced hepatocellular carcinoma treated with sorafenib
暂无分享,去创建一个
Bohyun Kim | J. Hwang | B. Yoo | K. Lee | D. Kang | S. Lim | S. Shin | J. Cheong | S. Cho | Kwang-Jae Lee | Jei Hee Lee | J. Nam | H. Cho | Min Jung Oh | Jai-Keun Kim | S. Kim | M. Yang | S. Shin